In contrast, IDO1 degradation would eliminate both, enzymatic activity and signaling function, and may open up new opportunities for the treatment of cancer or, as recent studies imply, the treatment of diseases related to Epstein Barr virus infections13. The gene discussed is IDO1; the disease is cancer.